Lv1
48 积分 2023-08-03 加入
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering
23小时前
待确认
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR T cell therapy
21天前
已完结
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion
25天前
已完结
Closed loop bioreactor system for the ex vivo expansion of human T cells
1个月前
已完结
Trispecific antibodies offer a third way forward for anticancer immunotherapy
1个月前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
1个月前
已完结
Cancer therapy with antibodies
1个月前
已完结
Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review
1个月前
已完结
ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion
1个月前
已完结
Transduction of Human T Cell Subsets with Lentivirus
1个月前
已完结
皖公网安备34019202002308
